These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 20513011)
1. Valproic acid administration for hepatic fibrosis: a balance between antifibrotic efficacy and hepatotoxicity. Ikura Y; Iwasa Y; Ueda M Hepatology; 2010 Jun; 51(6):2227-8; author reply 2228. PubMed ID: 20513011 [No Abstract] [Full Text] [Related]
2. Hepatotoxicity and valproate therapy. Betrosian A; Frantzeskaki F Intern Med J; 2006 Nov; 36(11):752-4. PubMed ID: 17040368 [No Abstract] [Full Text] [Related]
3. [Valproic acid induced-idiosyncratic hepatotoxicity]. Mata Zubillaga D; Prieto Espuñes S; Ferrero de la Mano L; Herrero Mendoza B An Pediatr (Barc); 2008 Nov; 69(5):492-3. PubMed ID: 19128756 [No Abstract] [Full Text] [Related]
4. [Severe liver damage following administration of valproic acid (Depakine)]. Coeckelberghs M; van Caillie-Bertrand M; Bultinck J; Clara R Ned Tijdschr Geneeskd; 1980 Aug; 124(34):1428-31. PubMed ID: 6774268 [No Abstract] [Full Text] [Related]
9. Valproic-acid-associated pancreatitis and hepatic toxicity in children with endstage renal disease. Levin TL; Berdon WE; Seigle RR; Nash MA Pediatr Radiol; 1997 Feb; 27(2):192-3. PubMed ID: 9028861 [No Abstract] [Full Text] [Related]
10. [Hepatotoxicity induced by valproic acid in adults. Report of 3 cases]. Galdames D; Silva C; Aguilera L; Chesta J Rev Med Chil; 1993 Dec; 121(12):1432-6. PubMed ID: 8085069 [TBL] [Abstract][Full Text] [Related]
11. Evidence for a potential protective effect of carnitine-pantothenic acid co-treatment on valproic acid-induced hepatotoxicity. Felker D; Lynn A; Wang S; Johnson DE Expert Rev Clin Pharmacol; 2014 Mar; 7(2):211-8. PubMed ID: 24450420 [TBL] [Abstract][Full Text] [Related]
12. Corticosteroid-Flared Hepatotoxicity Reversed With l -Carnitine Therapy in a Patient Treated With Long-Term Valproic Acid. Goren BI; Selvi E; Bektas B; Arslan F Am J Ther; 2022 Nov-Dec 01; 29(6):e774-e776. PubMed ID: 32496438 [No Abstract] [Full Text] [Related]
13. Remission of West syndrome associated with valproate hepatotoxicity. Go T Brain Dev; 2002 Jun; 24(4):257-9. PubMed ID: 12015170 [TBL] [Abstract][Full Text] [Related]
14. [Pathogenetic basis of pharmaceutical hepatitis induced by depakine in children]. Podymova SD; Sadovnikova IV Eksp Klin Gastroenterol; 2009; (8):30-5. PubMed ID: 20469676 [TBL] [Abstract][Full Text] [Related]
15. Effect of L-carnitine treatment for valproate-induced hepatotoxicity. DeVivo DC Neurology; 2002 Feb; 58(3):507-8. PubMed ID: 11839873 [No Abstract] [Full Text] [Related]
18. Acute hepatic injury in four children with Dravet syndrome: valproic acid, topiramate or acetaminophen? Nicolai J; Gunning B; Leroy PL; Ceulemans B; Vles JS Seizure; 2008 Jan; 17(1):92-7. PubMed ID: 17697789 [TBL] [Abstract][Full Text] [Related]
19. Hepatotoxicity from Depakene. FDA Drug Bull; 1981 Jul; 11(2):12-3. PubMed ID: 6788635 [No Abstract] [Full Text] [Related]
20. Cooccurrence of Two Different Genetic Diseases: A Case of Valproic Acid Hepatotoxicity in Nicolaides-Baraitser Syndrome (SMARCA2 Mutation)-Due to a POLG1-Related Effect? Hofmeister B; von Stülpnagel C; Berweck S; Abicht A; Kluger G; Weber P Neuropediatrics; 2020 Feb; 51(1):49-52. PubMed ID: 31541998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]